Springer Health+ IME, providing independent medical education in Neurology, Diabetes, Oncology, Rare Diseases, Endocrinology, and Paediatrics.
Global
- Tweets 1,991
- Following 2,761
- Followers 20,495
- Likes 314
In this patient-physician conversation, Dr. Kristen Flint unpicks real-world patient experiences with CGM, from adoption challenges to the importance of shared decision-making, highlighting the need for individualized strategies in diabetes care: diabetes-cgm.ime.springerhea…
1
818
Attending IMS 2026 and looking to stay ahead of the discussion on newly diagnosed multiple myeloma (NDMM)? Watch this free, on-demand webcast and discover how BCMA-directed therapies could reshape the frontline treatment paradigm in NDMM: ime.springermedicine.com/lea…
1
4
1,873
This World Alzheimer's Month, build your own personalized summary of best practices and clinical evidence on the use of biomarkers to support diagnosis, treatment selection and monitoring in Alzheimer’s disease using our free infographic builder: alzheimers-biomarkers-mdt.im…
1
1,084
Mark World Alzheimer’s Month by exploring the latest advances in PET imaging using these free, regionally focused clinical simulations, designed to optimize your selection, interpretation, and reporting of PET biomarkers in practice: navigate-imaging-alzheimers-…
1
1
3,167
Candidate selection and surgical considerations for presbyopia-correcting intraocular lenses: Start learning in these free, CME-accredited patient case modules, developed by Dr. Rahul Tonk and Dr. Caroline Watson: presbyopia-pc-iol-surgery.im…
2
2
1,167
Help shape the discussion at #ESCCongress 2026 by sharing your experience of managing patients with heart failure and kidney impairment.
Which unmet need in HF with kidney impairment management are you most hopeful new evidence will address?
57%
Combination therapies
0%
Better biomarkers
29%
K+ management tools
14%
Integrated HF/CKD care
7 votes • Final results
1
2,485
Unpick regional disparities and patient perspectives on systemic lupus erythematosus in this free, CME-accredited video series, led by Prof. Martin Aringer and international experts in lupus care: sle-guidelines-to-practice.i…
2
3
1,082
Help shape the discussion at #ESCCongress 2026 by sharing your experience of managing patients with heart failure and kidney impairment.
A patient's eGFR dips after starting an SGLT2 inhibitor. What's your first move?
33%
Continue and monitor
33%
Reduce the dose
33%
Stop the drug
0%
Refer to nephrology
3 votes • Final results
1
1
665
Hear from Dr. Larisa J. Geskin and fellow clinical experts in our free, CME-accredited webcast, where they explore the evolving therapeutic landscape of the tumor microenvironment in mycosis fungoides–type cutaneous T-cell lymphoma: ime.springermedicine.com/lea…
700
Help shape the discussion at #ESCCongress 2026 by sharing your experience of managing patients with heart failure and kidney impairment.
What's the biggest barrier to optimising HF GDMT in patients with kidney impairment?
0%
Fear of eGFR drop
0%
Hyperkalaemia risk
0%
Perceived stability
0%
Polypharmacy
0 votes • Final results
2
603
Looking to refine your decision-making skills in decoding HER2 mutations and overexpression in NSCLC? Explore our free, CME-accredited case scenarios to unpick the latest clinical trial data and emerging treatment regimens for HER2 NSCLC: her2-mutations-nsclc.ime.spr…
1
1
891
Help shape the discussion at #ESCCongress 2026 by sharing your experience of managing patients with heart failure and kidney impairment.
Which kidney biomarker most influences your heart failure management decisions?
100%
eGFR trajectory
0%
UACR/albuminuria
0%
Serum potassium
0%
Serum creatinine
1 votes • Final results
549
Help shape the discussion at #ESCCongress 2026 by sharing your experience of managing patients with heart failure and kidney impairment.
How often do you test UACR (urine albumin-to-creatinine ratio) in patients with HF?
0%
Routinely
100%
Occasionally
0%
Rarely
0%
Never
2 votes • Final results
745
BCMA-directed strategies in newly diagnosed multiple myeloma: What are the experts saying? Hear directly from our multidisciplinary faculty in this free, on-demand symposium webcast, recorded at COMy 2026: ime.springermedicine.com/lea…
2
3,105
Unpick the latest science-based insights into the pathophysiology, burden, and management of Lennox-Gastaut Syndrome (LGS) in our CME-accredited mini masterclass series, led by Andreea Nissenkorn, Antonio Gil-Nagel Rein, and Takamichi Yamamoto: lgs.ime.springermedicine.com…
1
1
2,568
We're excited to be attending #JAPhMed2026 in Tokyo!
Visit our booth to learn more about our IME programs and how we're supporting healthcare professionals in Japan with translated eLearning resources.
4
12
5,903
Ready to explore the clinical simulation? Put your PET tracer selection and interpretation skills for Alzheimer’s disease into practice using our free, case-based eLearning modules: navigate-imaging-alzheimers-…
2
8
1,879
Led by Dr. Vaishali Sanchorawala and Prof. Sebastian Spethmann, our free, interactive case files provide practical insights into building a sustainable MDT amyloidosis care framework, from streamlining care coordination to reducing diagnostic delays: amyloidosis-center-hub.ime.s…
1
5
2,144
Hear from Dr. Larisa J. Geskin and fellow clinical experts in our free, CME-accredited webcast, where they explore the evolving therapeutic landscape of the tumor microenvironment in mycosis fungoides–type cutaneous T-cell lymphoma: ime.springermedicine.com/lea…
1
8
6,948
COMy 2026: Watch the free, on-demand webcast of our interactive symposium, chaired by Prof. Mohamad Mohty, and discover how BCMA-directed therapies could reshape the frontline treatment paradigm in newly diagnosed multiple myeloma: ime.springermedicine.com/lea…
ALT COMy 2026: Watch the free, on-demand webcast of our interactive symposium, chaired by Prof. Mohamad Mohty, and discover how BCMA-directed therapies could reshape the frontline treatment paradigm in newly diagnosed multiple myeloma.
9
4
26
12,133